ethyl 5-amino-1-[6-(hydroxymethyl)-2,2-dimethyl-tetrahydro-2H-furo[3,4-d][1,3]dioxol-4-yl]-1H-imidazole-4-carboxylate



Compound IDCDAMM00130
Common nameethyl 5-amino-1-[6-(hydroxymethyl)-2,2-dimethyl-tetrahydro-2H-furo[3,4-d][1,3]dioxol-4-yl]-1H-imidazole-4-carboxylate
IUPAC nameethyl 5-amino-1-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]imidazole-4-carboxylate
Molecular formulaC14H21N3O6

Experimental data

Retention time29.81
Adduct[M+H]+
Actual mz328.151
Theoretical mz328.15
Error2.74
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.1364

Identifiers and class information

Inchi keyQNYWKJPANMXTCT-UHFFFAOYSA-N
SmilesCCOC(=O)C1=C(N(C=N1)C2C3C(C(O2)CO)OC(O3)(C)C)N
SuperclassNucleosides, nucleotides, and analogues
ClassImidazole ribonucleosides and ribonucleotides

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)327.336
Computed dipole moment(dipole)6.073
Total solvent accessible surface area (SASA)583.101
Hydrophobic component of SASA (FOSA)381.234
Hydrophilic component of SASA (FISA)160.416
Pie component of the SASA (PISA)41.451
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1014.78
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)7.9
Free energy of solvation of dipole (dip^2/V)0.0363395
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0191601
Globularity descriptor (glob)0.837532
Predicted polarizability in cubic angstroms (QPpolrz)31.643
Predicted hexadecane/gas partition coefficient (QPlogPC16)9.491
Predicted octanol/gas partition coefficient (QPlogPoct)17.728
Predicted water/gas partition coefficient (QPlogPw)12.103
Predicted octanol/water partition coefficient (QPlogPo/w)1.257
Predicted aqueous solubility (QPlogS)-3.429
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.241
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.359
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)298.318
Predicted brain/blood partition coefficient (QPlogBB)-1.262
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)133.826
Predicted skin permeability, log Kp (QPlogKp)-3.85
PM3 calculated ionization potential (IP(ev))8.136
PM3 calculated electron affinity (EA(eV))-0.448
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-0.3
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)78.595
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)121.546
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29274ADORA2AAdenosine A2a receptorT77365SEA
P30542ADORA1Adenosine A1 receptorT92072SEA
P0DMS8ADORA3Adenosine A3 receptorT36059SEA
P32320CDACytidine deaminase (by homology)T79027SEA
P00813ADAAdenosine deaminaseT03661SEA
P55263ADKAdenosine kinaseT91661SEA
P04406GAPDHGlyceraldehyde-3-phosphate dehydrogenase liverT39321SEA
Q99808SLC29A1Equilibrative nucleoside transporter 1T13491SEA
P23526AHCYAdenosylhomocysteinaseT68698SEA
P55786NPEPPSPuromycin-sensitive aminopeptidaseT15610SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q9UBC3DNMT3BDNA (cytosine-5)-methyltransferase 3BT65501SEA
P17707AMD1S-adenosylmethionine decarboxylase 1T55922SEA
Q9NVM4PRMT7Protein arginine N-methyltransferase 7T79501SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T77365DI0319Orthostatic hypotension[ICD-11: BA21]P29274ADORA2A
T77365DI0331Parkinsonism[ICD-11: 8A00]P29274ADORA2A
T77365DI0359Radionuclide imaging[ICD-11: N.A.]P29274ADORA2A
T92072DI0319Orthostatic hypotension[ICD-11: BA21]P30542ADORA1
T36059DI0351Psoriasis[ICD-11: EA90]P0DMS8ADORA3
T36059DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P0DMS8ADORA3
T79027DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P32320CDA
T03661DI0016Adaptive immunity immunodeficiency[ICD-11: 4A01]P00813ADA
T03661DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P00813ADA
T03661DI0249Mature B-cell leukaemia[ICD-11: 2A82]P00813ADA
T91661DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P55263ADK
T39321DI0279Muscular atrophy[ICD-11: 8B61]P04406GAPDH
T39321DI0280Muscular dystrophy[ICD-11: 8C70]P04406GAPDH
T13491DI0030Angina pectoris[ICD-11: BA40]Q99808SLC29A1
T15610DI0012Acute myeloid leukaemia[ICD-11: 2A60]P55786NPEPPS
T15610DI0284Myelodysplastic syndrome[ICD-11: 2A37]P55786NPEPPS
T65501DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9UBC3DNMT3B
T55922DI0004Acidosis[ICD-11: 5C73]P17707AMD1

Copyright © 2025